期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 23, 期 17, 页码 4903-4906出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2013.06.073
关键词
Necroptosis; Nec-21; Inhibitor; SAR study; RIP1; JNK3
资金
- National Natural Science Foundation of China [21072212]
- National Institute of Health of US [R37 AG012859]
An initial structure-activity relationship study of the novel necroptosis inhibitor Nec-21 was described. Any changes of the tetracyclic scaffold were detrimental for the activity. Introduction of a substituent to 7 or 8 position (e.g., cyano or methoxy group, respectively), would increase the activity. The 7 and 8-position disubstituted compound 17b was 35-fold as potent as the lead, while EC50 reached 14 nM. (C) 2013 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
